Breaking News
Top News
-
How to Respond to Requests to ‘Pick Your Brain’
-
Ulta (ULTA) Gained from New Leadership
-
First Thing: Trump describes ‘productive’ talks with Iran but Tehran denies contact
-
Adobe (ADBE) Reports Strong Earnings Despite Leadership Transition Concern
-
Truist Raises Vertex (VRTX) Price Target Following Phase 3 Trial Results
-
AppLovin (APP) Growth Driven by AI-Powered Advertising Platform
-
Palantir Stock Surges as AI Demand Accelerates Growth
-
Morgan Stanley Reiterates Overweight on Eli Lilly (LLY), Cites Growth Potential of New Platform
-
Broadcom (AVGO) Secures Long-Term Growth with Hyperscaler Deals
-
Erste Group Upgrades Meta (META) to Buy, Highlights the Company’s AI Investments
-
Tigress Financial Raises NVIDIA (NVDA) Price Target on Strong AI Growth
-
BofA Reaffirms Buy on IBM Stock Amid Agentic AI Expansion
-
Dell Technologies (DELL) Rated Outperform After Strong Earnings Beat
-
Analysts Rate Intuit (INTU) Buy as AI Threats Remain Limited
-
Comcast (CMCSA) Expands Wireless and Streaming Growth Strategy
-
Palo Alto (PANW) Buy Rating Backed by Strong Cybersecurity Demand
-
Cisco (CSCO) Rated Buy on Strong AI and Data Center Demand
-
Boeing (BA) Stock Rated Buy on Potential 500 Aircraft Deal
-
Johnson & Johnson (JNJ) Advances Bladder Cancer Treatment with 89% Response Rate
-
Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results
2026-02-05


































